Literature DB >> 33386346

Real-world Evidence Needs Careful Interpretation.

Peter Nash1.   

Abstract

Year:  2021        PMID： 33386346     DOI： 10.3899/jrheum.201004

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  1 in total

1.  Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data.

Authors:  Andrei Barbulescu; Johan Askling; Saedis Saevarsdottir; Seoyoung C Kim; Thomas Frisell
Journal:  Clin Pharmacol Ther       Date:  2022-06-23       Impact factor: 6.903
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.